JP2008512375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512375A5 JP2008512375A5 JP2007530389A JP2007530389A JP2008512375A5 JP 2008512375 A5 JP2008512375 A5 JP 2008512375A5 JP 2007530389 A JP2007530389 A JP 2007530389A JP 2007530389 A JP2007530389 A JP 2007530389A JP 2008512375 A5 JP2008512375 A5 JP 2008512375A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- halogenated
- alkylamino
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 methylenedioxy, ethylenedioxy, difluoromethylenedioxy Chemical group 0.000 claims description 59
- 150000001875 compounds Chemical class 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000012453 solvate Substances 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 116
- 229910052736 halogen Inorganic materials 0.000 claims 82
- 150000002367 halogens Chemical class 0.000 claims 82
- 125000003545 alkoxy group Chemical group 0.000 claims 64
- 125000004432 carbon atom Chemical group C* 0.000 claims 64
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 59
- 125000003118 aryl group Chemical group 0.000 claims 49
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 45
- 125000005518 carboxamido group Chemical group 0.000 claims 44
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 44
- 125000004093 cyano group Chemical group *C#N 0.000 claims 44
- 125000004043 oxo group Chemical group O=* 0.000 claims 36
- 125000006413 ring segment Chemical group 0.000 claims 36
- 125000003282 alkyl amino group Chemical group 0.000 claims 35
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 25
- 125000005842 heteroatom Chemical group 0.000 claims 24
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 21
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 18
- 125000001072 heteroaryl group Chemical group 0.000 claims 17
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims 15
- 125000000623 heterocyclic group Chemical group 0.000 claims 15
- 229910052757 nitrogen Inorganic materials 0.000 claims 13
- 125000004429 atom Chemical group 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000003710 aryl alkyl group Chemical group 0.000 claims 8
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 6
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 125000002950 monocyclic group Chemical group 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 5
- 125000003003 spiro group Chemical group 0.000 claims 5
- 230000005494 condensation Effects 0.000 claims 4
- 238000009833 condensation Methods 0.000 claims 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- TXPILWAPMMLHJD-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-(5,5-dimethyl-3-propan-2-yl-4h-imidazol-2-yl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=NC(C)(C)CN1C(C)C TXPILWAPMMLHJD-UHFFFAOYSA-N 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- FTYINNHZXABEHV-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-2-(6,7-dimethoxycinnolin-4-yl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=C(Cl)C(Cl)=C1 FTYINNHZXABEHV-UHFFFAOYSA-N 0.000 claims 2
- XTWAKKXTDSUGOS-UHFFFAOYSA-N 2-(4-bromophenyl)-2-(6,7-dimethoxycinnolin-4-yl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=C(Br)C=C1 XTWAKKXTDSUGOS-UHFFFAOYSA-N 0.000 claims 2
- WOEAUZNQSRAKPQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(6,7-dimethoxycinnolin-4-yl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=C(Cl)C=C1 WOEAUZNQSRAKPQ-UHFFFAOYSA-N 0.000 claims 2
- PLJZYAFCOGDGNX-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-(3,4-dimethoxyphenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C(C(N)=O)C1=CN=NC2=CC(OC)=C(OC)C=C12 PLJZYAFCOGDGNX-UHFFFAOYSA-N 0.000 claims 2
- YLSZVBZFCPBVII-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-(3,4-dimethoxyphenyl)acetonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C(C#N)C1=CN=NC2=CC(OC)=C(OC)C=C12 YLSZVBZFCPBVII-UHFFFAOYSA-N 0.000 claims 2
- ZYSUMERKOHPDOJ-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-(3-methoxyphenyl)acetonitrile Chemical compound COC1=CC=CC(C(C#N)C=2C3=CC(OC)=C(OC)C=C3N=NC=2)=C1 ZYSUMERKOHPDOJ-UHFFFAOYSA-N 0.000 claims 2
- QHWSODILBGWLRR-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-(4-iodophenyl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=C(I)C=C1 QHWSODILBGWLRR-UHFFFAOYSA-N 0.000 claims 2
- MYNHHZKMOJJOKR-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-naphthalen-1-ylacetonitrile Chemical compound C1=CC=C2C(C(C#N)C=3C=NN=C4C=C(C(=CC4=3)OC)OC)=CC=CC2=C1 MYNHHZKMOJJOKR-UHFFFAOYSA-N 0.000 claims 2
- ZQBREKXGBSUNFB-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C(N)=O)C1=CC=CC=C1 ZQBREKXGBSUNFB-UHFFFAOYSA-N 0.000 claims 2
- JGAVKJBRMPBFBJ-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-2-phenylacetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=CC=C1 JGAVKJBRMPBFBJ-UHFFFAOYSA-N 0.000 claims 2
- BYSFIYKUHMVOGE-UHFFFAOYSA-N 4-[(6,7-dimethoxycinnolin-4-yl)methyl]aniline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1CC1=CC=C(N)C=C1 BYSFIYKUHMVOGE-UHFFFAOYSA-N 0.000 claims 2
- VHNOBOJCNXVUKR-UHFFFAOYSA-N 4-benzyl-6,7-dimethoxycinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1CC1=CC=CC=C1 VHNOBOJCNXVUKR-UHFFFAOYSA-N 0.000 claims 2
- 235000014676 Phragmites communis Nutrition 0.000 claims 2
- GIMRTVVCWHSTFP-UHFFFAOYSA-N 2-(4-aminophenyl)-2-(6,7-dimethoxycinnolin-4-yl)acetonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C#N)C1=CC=C(N)C=C1 GIMRTVVCWHSTFP-UHFFFAOYSA-N 0.000 claims 1
- 101100240518 Caenorhabditis elegans nhr-12 gene Proteins 0.000 claims 1
- 101100240529 Caenorhabditis elegans nhr-25 gene Proteins 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- JAKDMTBLDOEDGS-UHFFFAOYSA-N carbonocyanidoylcarbamic acid Chemical compound OC(=O)NC(=O)C#N JAKDMTBLDOEDGS-UHFFFAOYSA-N 0.000 claims 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000000034 method Methods 0.000 description 54
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 47
- 239000012458 free base Substances 0.000 description 6
- FVRZRBLXXKWSMJ-UHFFFAOYSA-N 6,7-bis(difluoromethoxy)-4-[7-(2-methoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound FC(F)OC1=C(OC(F)F)C=C2C(N3CCC4=CC=C(C=C4C3)OCCOC)=CN=NC2=C1 FVRZRBLXXKWSMJ-UHFFFAOYSA-N 0.000 description 3
- NNFLIFDMYPNKRY-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n,n-di(propan-2-yl)-2,3-dihydroindole-5-sulfonamide Chemical compound C1CC2=CC(S(=O)(=O)N(C(C)C)C(C)C)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 NNFLIFDMYPNKRY-UHFFFAOYSA-N 0.000 description 2
- POURBHXUHGOPLA-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n,n-diethyl-2,3-dihydroindole-5-sulfonamide Chemical compound COC1=C(OC)C=C2C(N3C4=CC=C(C=C4CC3)S(=O)(=O)N(CC)CC)=CN=NC2=C1 POURBHXUHGOPLA-UHFFFAOYSA-N 0.000 description 2
- ZQRGVXLGJMFEIG-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n,n-dimethyl-2,3-dihydroindole-5-sulfonamide Chemical compound C1CC2=CC(S(=O)(=O)N(C)C)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 ZQRGVXLGJMFEIG-UHFFFAOYSA-N 0.000 description 2
- LSLXTPJDYMMHPI-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n,n-dimethyl-3,4-dihydro-2h-quinoline-5-sulfonamide Chemical compound C1CCC(C(=CC=C2)S(=O)(=O)N(C)C)=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 LSLXTPJDYMMHPI-UHFFFAOYSA-N 0.000 description 2
- IOKRNMFSIHZDOP-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n-methyl-2,3-dihydroindole-5-sulfonamide Chemical compound COC1=C(OC)C=C2C(N3C4=CC=C(C=C4CC3)S(=O)(=O)NC)=CN=NC2=C1 IOKRNMFSIHZDOP-UHFFFAOYSA-N 0.000 description 2
- GZWZRLCOIXOBRQ-UHFFFAOYSA-N 2-[2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinolin-6-yl]-1,3-thiazole Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=CC=2)CCC1=CC=2C1=NC=CS1 GZWZRLCOIXOBRQ-UHFFFAOYSA-N 0.000 description 2
- CQRRHHPWUJJTHP-UHFFFAOYSA-N 2-[[2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinolin-5-yl]oxy]ethanol Chemical compound C1CC(C(=CC=C2)OCCO)=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 CQRRHHPWUJJTHP-UHFFFAOYSA-N 0.000 description 2
- BTEIKDBTCZKKPW-UHFFFAOYSA-N 4-(2,3-dihydroindol-1-yl)-6,7-dimethoxycinnoline Chemical compound C1CC2=CC=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 BTEIKDBTCZKKPW-UHFFFAOYSA-N 0.000 description 2
- BBAUDMBRCBBHFH-UHFFFAOYSA-N 4-(5,6-dimethoxy-2,3-dihydroindol-1-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=C(C(=CC=43)OC)OC)=CN=NC2=C1 BBAUDMBRCBBHFH-UHFFFAOYSA-N 0.000 description 2
- HCZDYRZLCZJNFP-UHFFFAOYSA-N 4-(5,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CC=4C=C(C=C(OC)C=4CC3)OC)=CN=NC2=C1 HCZDYRZLCZJNFP-UHFFFAOYSA-N 0.000 description 2
- YLEZBLOKYQYOMA-UHFFFAOYSA-N 4-(5-fluoro-2,3-dihydroindol-1-yl)-6,7-dimethoxycinnoline Chemical compound C1CC2=CC(F)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 YLEZBLOKYQYOMA-UHFFFAOYSA-N 0.000 description 2
- BTYSGBSCUFXRKJ-UHFFFAOYSA-N 4-(6,7-dimethoxy-3,4-dihydro-2h-quinolin-1-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CCCC=4C=C(C(=CC=43)OC)OC)=CN=NC2=C1 BTYSGBSCUFXRKJ-UHFFFAOYSA-N 0.000 description 2
- SEOHIUYTUBADSH-UHFFFAOYSA-N 4-(6,7-dimethoxy-3-methyl-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3C(C)CC=4C=C(C(=CC=4C3)OC)OC)=CN=NC2=C1 SEOHIUYTUBADSH-UHFFFAOYSA-N 0.000 description 2
- UKNKYJFZKAQECP-UHFFFAOYSA-N 4-(6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=C(C=C(OC)C=4C3)OC)=CN=NC2=C1 UKNKYJFZKAQECP-UHFFFAOYSA-N 0.000 description 2
- XKULTBKENQYYLA-UHFFFAOYSA-N 4-[1-(6,7-dimethoxycinnolin-4-yl)-2,3-dihydroindol-5-yl]-3,5-dimethyl-1,2-oxazole Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2C=1C(C)=NOC=1C XKULTBKENQYYLA-UHFFFAOYSA-N 0.000 description 2
- HHVHYDPGMSABGN-UHFFFAOYSA-N 4-[2-[[2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinolin-7-yl]oxy]ethyl]morpholine Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=C2)CCC1=CC=C2OCCN1CCOCC1 HHVHYDPGMSABGN-UHFFFAOYSA-N 0.000 description 2
- BOFIMTVRHLKDCF-UHFFFAOYSA-N 4-[5-(furan-3-yl)-2,3-dihydroindol-1-yl]-6,7-dimethoxycinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2C=1C=COC=1 BOFIMTVRHLKDCF-UHFFFAOYSA-N 0.000 description 2
- PGZUXNKXYXECQK-UHFFFAOYSA-N 4-indol-1-yl-6,7-dimethoxycinnoline Chemical compound C1=CC2=CC=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 PGZUXNKXYXECQK-UHFFFAOYSA-N 0.000 description 2
- GAHIEDPDVBNUHX-UHFFFAOYSA-N 5-(6,7-dimethoxycinnolin-4-yl)-6,7-dihydro-4h-thieno[3,2-c]pyridine Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1)CCC2=C1C=CS2 GAHIEDPDVBNUHX-UHFFFAOYSA-N 0.000 description 2
- SLCRRRBTRFLSTK-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound COC1=C(OC)C=C2C(N3CC=4C=CC=C(C=4CC3)OC)=CN=NC2=C1 SLCRRRBTRFLSTK-UHFFFAOYSA-N 0.000 description 2
- OMDAZDBGAWVQNA-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-methyl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C1CC2=CC(C)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 OMDAZDBGAWVQNA-UHFFFAOYSA-N 0.000 description 2
- WEZQNIUXSYFKMW-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-methyl-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC2=C(C)C=CC=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 WEZQNIUXSYFKMW-UHFFFAOYSA-N 0.000 description 2
- IFYQWMOMKBERPH-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-methylsulfonyl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C1CC2=CC(S(C)(=O)=O)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 IFYQWMOMKBERPH-UHFFFAOYSA-N 0.000 description 2
- FIJSPTJUNAZLPX-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-nitro-2,3-dihydroindol-1-yl)cinnoline Chemical compound C1CC2=CC([N+]([O-])=O)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 FIJSPTJUNAZLPX-UHFFFAOYSA-N 0.000 description 2
- MWPLLCFSKZOHBL-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-piperidin-1-ylsulfonyl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2S(=O)(=O)N1CCCCC1 MWPLLCFSKZOHBL-UHFFFAOYSA-N 0.000 description 2
- ZBWISBWZXLBRIB-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-pyridin-4-yl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2C1=CC=NC=C1 ZBWISBWZXLBRIB-UHFFFAOYSA-N 0.000 description 2
- YBJNCSDFHIRJJE-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-pyrimidin-5-yl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2C1=CN=CN=C1 YBJNCSDFHIRJJE-UHFFFAOYSA-N 0.000 description 2
- OTWJLDACLQSOBU-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-pyrrolidin-1-ylsulfonyl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2S(=O)(=O)N1CCCC1 OTWJLDACLQSOBU-UHFFFAOYSA-N 0.000 description 2
- OAAPFRNERYUJMQ-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-thiophen-3-yl-2,3-dihydroindol-1-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C1=CC=2)CCC1=CC=2C=1C=CSC=1 OAAPFRNERYUJMQ-UHFFFAOYSA-N 0.000 description 2
- ZFSASIYROXOIJI-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-methyl-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC2=CC(C)=CC=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 ZFSASIYROXOIJI-UHFFFAOYSA-N 0.000 description 2
- QOJKBDRJOWQNEH-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-methyl-3,4-dihydro-2h-quinolin-1-yl)cinnoline Chemical compound C1CCC2=CC(C)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 QOJKBDRJOWQNEH-UHFFFAOYSA-N 0.000 description 2
- BZKLTFMCOAKVDP-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-nitro-2,3-dihydroindol-1-yl)cinnoline Chemical compound C1CC2=CC=C([N+]([O-])=O)C=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 BZKLTFMCOAKVDP-UHFFFAOYSA-N 0.000 description 2
- YKSYMHIUFOUCDP-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-pyridin-4-yl-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=CC=2)CCC1=CC=2C1=CC=NC=C1 YKSYMHIUFOUCDP-UHFFFAOYSA-N 0.000 description 2
- FYEWSCPMQWHIBK-UHFFFAOYSA-N 6,7-dimethoxy-4-(7-methoxy-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C=C4C3)OC)=CN=NC2=C1 FYEWSCPMQWHIBK-UHFFFAOYSA-N 0.000 description 2
- JCHKSTGCLCUFFP-UHFFFAOYSA-N 6,7-dimethoxy-4-(7-methyl-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC2=CC=C(C)C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 JCHKSTGCLCUFFP-UHFFFAOYSA-N 0.000 description 2
- JDROTXPNEQQRMQ-UHFFFAOYSA-N 6,7-dimethoxy-4-(7-phenoxy-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=C2)CCC1=CC=C2OC1=CC=CC=C1 JDROTXPNEQQRMQ-UHFFFAOYSA-N 0.000 description 2
- AAGDWRQSUYNVGK-UHFFFAOYSA-N 6,7-dimethoxy-4-(8-methyl-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC2=CC=CC(C)=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 AAGDWRQSUYNVGK-UHFFFAOYSA-N 0.000 description 2
- DYHIEXGDCWFEKB-UHFFFAOYSA-N 6,7-dimethoxy-4-[6-(2-methoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound COC1=C(OC)C=C2C(N3CC4=CC=C(C=C4CC3)OCCOC)=CN=NC2=C1 DYHIEXGDCWFEKB-UHFFFAOYSA-N 0.000 description 2
- ZULINLCYCUHJIS-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(2-methoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C=C4C3)OCCOC)=CN=NC2=C1 ZULINLCYCUHJIS-UHFFFAOYSA-N 0.000 description 2
- MQMOVGUJXTWXQQ-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(2-phenylmethoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=C2)CCC1=CC=C2OCCOCC1=CC=CC=C1 MQMOVGUJXTWXQQ-UHFFFAOYSA-N 0.000 description 2
- KQQAMESYTATFRN-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(oxolan-3-yloxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1=C2)CCC1=CC=C2OC1CCOC1 KQQAMESYTATFRN-UHFFFAOYSA-N 0.000 description 2
- YXGMHQZBNWGZTG-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(trifluoromethyl)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound C1CC2=CC=C(C(F)(F)F)C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 YXGMHQZBNWGZTG-UHFFFAOYSA-N 0.000 description 2
- DCNNWEYEHXLFDH-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(trifluoromethyl)-3,4-dihydro-2h-quinolin-1-yl]cinnoline Chemical compound C1CCC2=CC=C(C(F)(F)F)C=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 DCNNWEYEHXLFDH-UHFFFAOYSA-N 0.000 description 2
- SVDBKJMXAQXDOE-UHFFFAOYSA-N 6,7-dimethoxy-4-[8-(2-methoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=CC=C(C=4C3)OCCOC)=CN=NC2=C1 SVDBKJMXAQXDOE-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- YONRJCKACFAXFG-UHFFFAOYSA-N methyl 2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinoline-6-carboxylate Chemical compound COC1=C(OC)C=C2C(N3CC4=CC=C(C=C4CC3)C(=O)OC)=CN=NC2=C1 YONRJCKACFAXFG-UHFFFAOYSA-N 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XJAHKXBDITVEBH-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n-ethyl-2,3-dihydroindole-5-sulfonamide Chemical compound COC1=C(OC)C=C2C(N3C4=CC=C(C=C4CC3)S(=O)(=O)NCC)=CN=NC2=C1 XJAHKXBDITVEBH-UHFFFAOYSA-N 0.000 description 1
- SQMPOZHFZQXYEO-UHFFFAOYSA-N 1-(6,7-dimethoxycinnolin-4-yl)-n-propan-2-yl-2,3-dihydroindole-5-sulfonamide Chemical compound C1CC2=CC(S(=O)(=O)NC(C)C)=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 SQMPOZHFZQXYEO-UHFFFAOYSA-N 0.000 description 1
- KGADJGCFVJEQFY-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-1,3-thiazole Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C1=NC=CS1 KGADJGCFVJEQFY-UHFFFAOYSA-N 0.000 description 1
- XGIZPHGCZHLEEK-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinoline-5-carboxylic acid;hydrochloride Chemical compound Cl.C1CC(C(=CC=C2)C(O)=O)=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 XGIZPHGCZHLEEK-UHFFFAOYSA-N 0.000 description 1
- BZDWBXDEEGYERR-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinoline-7-carbonitrile Chemical compound C1CC2=CC=C(C#N)C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 BZDWBXDEEGYERR-UHFFFAOYSA-N 0.000 description 1
- ZMFMYECPHFNUET-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-5-(2-methoxyethoxy)-3,4-dihydroisoquinolin-1-one Chemical compound COC1=C(OC)C=C2C(N3C(=O)C=4C=CC=C(C=4CC3)OCCOC)=CN=NC2=C1 ZMFMYECPHFNUET-UHFFFAOYSA-N 0.000 description 1
- SMFQJUWQEWNMIA-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-5-hydroxy-3,4-dihydroisoquinolin-1-one Chemical compound C1CC2=C(O)C=CC=C2C(=O)N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 SMFQJUWQEWNMIA-UHFFFAOYSA-N 0.000 description 1
- YBIWULXJHODBGK-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-6,7-dimethoxy-1,4-dihydroisoquinolin-3-one Chemical compound COC1=C(OC)C=C2C(N3CC=4C=C(C(=CC=4CC3=O)OC)OC)=CN=NC2=C1 YBIWULXJHODBGK-UHFFFAOYSA-N 0.000 description 1
- VRQIIAJTDJLBSD-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-6-fluoro-3,4-dihydroisoquinolin-1-one Chemical compound C1CC2=CC(F)=CC=C2C(=O)N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 VRQIIAJTDJLBSD-UHFFFAOYSA-N 0.000 description 1
- YBSKKKPJSFWXFA-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-6-phenylmethoxy-3,4-dihydroisoquinolin-1-one Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(C(C1=CC=2)=O)CCC1=CC=2OCC1=CC=CC=C1 YBSKKKPJSFWXFA-UHFFFAOYSA-N 0.000 description 1
- YZQSIFYRRBRSAK-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-7,8-dimethoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C(=C4C3=O)OC)OC)=CN=NC2=C1 YZQSIFYRRBRSAK-UHFFFAOYSA-N 0.000 description 1
- HXTDVGBZJYUBAQ-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-7-fluoro-6-methoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=C(C(=CC=4C3=O)F)OC)=CN=NC2=C1 HXTDVGBZJYUBAQ-UHFFFAOYSA-N 0.000 description 1
- NYIDQRNCWLSUKW-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-7-methoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C=C4C3=O)OC)=CN=NC2=C1 NYIDQRNCWLSUKW-UHFFFAOYSA-N 0.000 description 1
- YEKSPXSXUBOHFL-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-8-fluoro-7-methoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C(=C4C3=O)F)OC)=CN=NC2=C1 YEKSPXSXUBOHFL-UHFFFAOYSA-N 0.000 description 1
- VTYKXOCEEIAVSU-UHFFFAOYSA-N 2-(6,7-dimethoxycinnolin-4-yl)-8-methoxy-4,5-dihydro-3h-2-benzazepin-1-one Chemical compound O=C1C2=CC(OC)=CC=C2CCCN1C1=CN=NC2=CC(OC)=C(OC)C=C12 VTYKXOCEEIAVSU-UHFFFAOYSA-N 0.000 description 1
- JPHKPRRMDSTLKO-UHFFFAOYSA-N 3-(6,7-dimethoxycinnolin-4-yl)-n,n-diethylbenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C=2C3=CC(OC)=C(OC)C=C3N=NC=2)=C1 JPHKPRRMDSTLKO-UHFFFAOYSA-N 0.000 description 1
- TUWFLGAMQLJBFY-UHFFFAOYSA-N 3-(6,7-dimethoxycinnolin-4-yl)-n-(2-methylpropyl)benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C1=CC=CC(C(=O)NCC(C)C)=C1 TUWFLGAMQLJBFY-UHFFFAOYSA-N 0.000 description 1
- ZPKCZUPLQIVTRA-UHFFFAOYSA-N 3-(6,7-dimethoxycinnolin-4-yl)-n-ethylbenzamide Chemical compound CCNC(=O)C1=CC=CC(C=2C3=CC(OC)=C(OC)C=C3N=NC=2)=C1 ZPKCZUPLQIVTRA-UHFFFAOYSA-N 0.000 description 1
- SBKKRZKYBPVSIA-UHFFFAOYSA-N 3-[4-(6,7-dimethoxycinnolin-4-yl)piperazin-1-yl]-1,2-benzothiazole Chemical compound C1=CC=C2C(N3CCN(CC3)C=3C=NN=C4C=C(C(=CC4=3)OC)OC)=NSC2=C1 SBKKRZKYBPVSIA-UHFFFAOYSA-N 0.000 description 1
- SLQNTTDAAFJJEY-UHFFFAOYSA-N 4-(1,3-dihydroisoindol-2-yl)-6,7-dimethoxycinnoline Chemical compound C1C2=CC=CC=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 SLQNTTDAAFJJEY-UHFFFAOYSA-N 0.000 description 1
- WYUYTSWOLNCGCY-UHFFFAOYSA-N 4-(1-benzylpyrazol-4-yl)-6,7-dimethoxycinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(=C1)C=NN1CC1=CC=CC=C1 WYUYTSWOLNCGCY-UHFFFAOYSA-N 0.000 description 1
- RFGMTCKSOWLUJB-UHFFFAOYSA-N 4-(3,4-dihydro-2h-quinolin-1-yl)-6,7-dimethoxycinnoline Chemical compound C1CCC2=CC=CC=C2N1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 RFGMTCKSOWLUJB-UHFFFAOYSA-N 0.000 description 1
- CGRADXTUYGVTED-UHFFFAOYSA-N 4-(3,4-dihydronaphthalen-2-yl)-6,7-dimethoxycinnoline Chemical compound C1=CC=C2CCC(C=3C=NN=C4C=C(C(=CC4=3)OC)OC)=CC2=C1 CGRADXTUYGVTED-UHFFFAOYSA-N 0.000 description 1
- ZGVXYVJSVXNUPY-UHFFFAOYSA-N 4-(6,7-diethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=C(C(=CC=4C3)OCC)OCC)=CN=NC2=C1 ZGVXYVJSVXNUPY-UHFFFAOYSA-N 0.000 description 1
- GISLEWHHSSVLRY-UHFFFAOYSA-N 4-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound COC1=C(OC)C=C2C(N3CCC=4C=C(C(=CC=4C3)OC)OC)=CN=NC2=C1 GISLEWHHSSVLRY-UHFFFAOYSA-N 0.000 description 1
- SWHWUCJEWCMZAN-UHFFFAOYSA-N 4-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline;hydrochloride Chemical compound Cl.COC1=C(OC)C=C2C(N3CCC=4C=C(C(=CC=4C3)OC)OC)=CN=NC2=C1 SWHWUCJEWCMZAN-UHFFFAOYSA-N 0.000 description 1
- PFPLJYUNHMUIBK-UHFFFAOYSA-N 4-(6,7-dimethoxycinnolin-4-yl)morpholine Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N1CCOCC1 PFPLJYUNHMUIBK-UHFFFAOYSA-N 0.000 description 1
- YSTNNWAZXRXUCZ-UHFFFAOYSA-N 4-(7-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)-6,7-dimethoxycinnoline Chemical compound C1CC2=CC=C(F)C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 YSTNNWAZXRXUCZ-UHFFFAOYSA-N 0.000 description 1
- WKIJECDMHIJKJO-ZIAGYGMSSA-N 4-[(4ar,8as)-3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl]-6,7-dimethoxycinnoline Chemical compound C([C@@H]1CC2)CCC[C@@H]1CN2C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 WKIJECDMHIJKJO-ZIAGYGMSSA-N 0.000 description 1
- RERFEFRUWNQRAM-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-6,7-dimethoxycinnoline Chemical compound C1=C2OCOC2=CC(CN2CCN(CC2)C=2C=NN=C3C=C(C(=CC3=2)OC)OC)=C1 RERFEFRUWNQRAM-UHFFFAOYSA-N 0.000 description 1
- MGQGAUYGSMGVCL-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-6,7-dimethoxycinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1)CCN1C1=CC=CC(Cl)=C1 MGQGAUYGSMGVCL-UHFFFAOYSA-N 0.000 description 1
- YTCOEWREDJXXNU-UHFFFAOYSA-N 4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-6,7-dimethoxycinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N(CC1)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 YTCOEWREDJXXNU-UHFFFAOYSA-N 0.000 description 1
- YTEFCXAEBGDBMJ-UHFFFAOYSA-N 6,7-dimethoxy-4-(5-nitro-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC(C(=CC=C2)[N+]([O-])=O)=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 YTEFCXAEBGDBMJ-UHFFFAOYSA-N 0.000 description 1
- ZTHWRYLNBMWXMX-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound COC1=C(OC)C=C2C(N3CC4=CC=C(C=C4CC3)OC)=CN=NC2=C1 ZTHWRYLNBMWXMX-UHFFFAOYSA-N 0.000 description 1
- QFTPBTLPDLUTDX-UHFFFAOYSA-N 6,7-dimethoxy-4-(6-methoxynaphthalen-2-yl)cinnoline Chemical compound COC1=C(OC)C=C2C(C3=CC4=CC=C(C=C4C=C3)OC)=CN=NC2=C1 QFTPBTLPDLUTDX-UHFFFAOYSA-N 0.000 description 1
- LRCQOFIVACKEKQ-UHFFFAOYSA-N 6,7-dimethoxy-4-(7-nitro-3,4-dihydro-1h-isoquinolin-2-yl)cinnoline Chemical compound C1CC2=CC=C([N+]([O-])=O)C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 LRCQOFIVACKEKQ-UHFFFAOYSA-N 0.000 description 1
- MKXSICLWMVIVEM-UHFFFAOYSA-N 6,7-dimethoxy-4-[7-(2-methoxyethoxy)-3,4-dihydro-1h-isoquinolin-2-yl]cinnoline;hydrochloride Chemical compound Cl.COC1=C(OC)C=C2C(N3CCC4=CC=C(C=C4C3)OCCOC)=CN=NC2=C1 MKXSICLWMVIVEM-UHFFFAOYSA-N 0.000 description 1
- MCYOXSRPKGLONG-UHFFFAOYSA-N 6,7-dimethoxy-4-piperidin-1-ylcinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1N1CCCCC1 MCYOXSRPKGLONG-UHFFFAOYSA-N 0.000 description 1
- BLMGWYVQBYZFKI-UHFFFAOYSA-N 6,7-dimethoxy-4-pyridin-3-ylcinnoline Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C1=CC=CN=C1 BLMGWYVQBYZFKI-UHFFFAOYSA-N 0.000 description 1
- AOLNCUWKDDNLBW-UHFFFAOYSA-N 6,7-dimethoxy-n-(5-methyl-4h-pyrazol-3-yl)cinnolin-4-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1NC1=NN=C(C)C1 AOLNCUWKDDNLBW-UHFFFAOYSA-N 0.000 description 1
- GMPHIAUPDXPTLP-UHFFFAOYSA-N 6-(6,7-dimethoxycinnolin-4-yl)-7,8-dihydro-5h-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1CC2=CC=3OCOC=3C=C2CN1C1=C(C=C(C(OC)=C2)OC)C2=NN=C1 GMPHIAUPDXPTLP-UHFFFAOYSA-N 0.000 description 1
- AOPYCLUANCJPLW-UHFFFAOYSA-N 6-(cyclopropylmethoxy)-2-(6,7-dimethoxycinnolin-4-yl)-7-methoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=CC=2C(=O)N(C=3C4=CC(OC)=C(OC)C=C4N=NC=3)CCC=2C=C1OCC1CC1 AOPYCLUANCJPLW-UHFFFAOYSA-N 0.000 description 1
- HDGOIKZJODPQBD-UHFFFAOYSA-N 7-(cyclopropylmethoxy)-2-(6,7-dimethoxycinnolin-4-yl)-6-methoxy-3,4-dihydroisoquinolin-1-one Chemical compound COC1=CC=2CCN(C=3C4=CC(OC)=C(OC)C=C4N=NC=3)C(=O)C=2C=C1OCC1CC1 HDGOIKZJODPQBD-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- QJIBBSKRQXMOER-UHFFFAOYSA-N methyl 2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinoline-5-carboxylate Chemical compound COC1=C(OC)C=C2C(N3CC=4C=CC=C(C=4CC3)C(=O)OC)=CN=NC2=C1 QJIBBSKRQXMOER-UHFFFAOYSA-N 0.000 description 1
- XKVFRADFBWVPGS-UHFFFAOYSA-N methyl 2-(6,7-dimethoxycinnolin-4-yl)-3,4-dihydro-1h-isoquinoline-7-carboxylate Chemical compound COC1=C(OC)C=C2C(N3CCC4=CC=C(C=C4C3)C(=O)OC)=CN=NC2=C1 XKVFRADFBWVPGS-UHFFFAOYSA-N 0.000 description 1
- KPPDYGAMNNDOFX-UHFFFAOYSA-N n-(6,7-dimethoxycinnolin-4-yl)-4-methyl-1,3-thiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1NC1=NC(C)=CS1 KPPDYGAMNNDOFX-UHFFFAOYSA-N 0.000 description 1
- MLXZHRASGIMQSJ-UHFFFAOYSA-N n-cyclohexyl-3-(6,7-dimethoxycinnolin-4-yl)benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C=1)=CC=CC=1C(=O)NC1CCCCC1 MLXZHRASGIMQSJ-UHFFFAOYSA-N 0.000 description 1
- NZZVPKXDCWMYMD-UHFFFAOYSA-N n-cyclopropyl-3-(6,7-dimethoxycinnolin-4-yl)benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NN=CC=1C(C=1)=CC=CC=1C(=O)NC1CC1 NZZVPKXDCWMYMD-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60689504P | 2004-09-03 | 2004-09-03 | |
| PCT/US2005/031283 WO2006028957A1 (en) | 2004-09-03 | 2005-09-02 | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008512375A JP2008512375A (ja) | 2008-04-24 |
| JP2008512375A5 true JP2008512375A5 (enExample) | 2009-02-19 |
Family
ID=35466083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530389A Pending JP2008512375A (ja) | 2004-09-03 | 2005-09-02 | 精神医学的又は神経学的症候群の治療用のホスホジエステラーゼ１０阻害剤としての４−置換４，６−ジアルコキシ−シンノリン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060160814A1 (enExample) |
| EP (1) | EP1802585A1 (enExample) |
| JP (1) | JP2008512375A (enExample) |
| AU (1) | AU2005282721A1 (enExample) |
| CA (1) | CA2578996A1 (enExample) |
| MX (1) | MX2007002592A (enExample) |
| WO (1) | WO2006028957A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007010572A (es) * | 2005-03-01 | 2007-10-04 | Wyeth Corp | Compuestos de cinolina y su uso como moduladores de receptor x de higado. |
| JP5099814B2 (ja) * | 2006-02-02 | 2012-12-19 | 田辺三菱製薬株式会社 | 含窒素複素二環式化合物 |
| MX2008010671A (es) * | 2006-02-21 | 2008-10-01 | Amgen Inc | Derivados de cinolina como inhibidores de fosfodiesterasa 10. |
| EP1991530A1 (en) * | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| WO2007100880A1 (en) * | 2006-02-28 | 2007-09-07 | Amgen Inc. | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| PT2057153E (pt) | 2006-07-10 | 2012-11-14 | Lundbeck & Co As H | Derivados (3-aril-piperazin-1-il) de 6,7- dialcoxiquinazolina, 6,7-dialcoxiftalazina e 6,7-dialcoxiisoquinolina |
| US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| WO2009025839A2 (en) * | 2007-08-22 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
| US7858620B2 (en) | 2007-09-19 | 2010-12-28 | H. Lundbeck A/S | Cyanoisoquinoline |
| US20100267712A1 (en) * | 2007-09-27 | 2010-10-21 | The United States of America, as represented by the Secretary, Department of Health and | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| UA102693C2 (ru) | 2008-06-20 | 2013-08-12 | Х. Луннбек А/С | Производные фенилимидазола как ингибиторы фермента pde10a |
| TW201200516A (en) | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
| TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
| TWI481607B (zh) | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物 |
| TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
| TW201206935A (en) | 2010-07-16 | 2012-02-16 | Lundbeck & Co As H | Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor |
| JO3089B1 (ar) | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
| MX2013009575A (es) * | 2011-02-18 | 2014-10-14 | Exonhit Therapeutics Sa | Derivados de 6, 7-dialcoxi-3-isoquinolinol sustituidos como inhibidores de fosfodiesterasa 10 (pdei0a). |
| US9938269B2 (en) | 2011-06-30 | 2018-04-10 | Abbvie Inc. | Inhibitor compounds of phosphodiesterase type 10A |
| WO2013045607A1 (en) | 2011-09-30 | 2013-04-04 | H. Lundbeck A/S | Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
| WO2013050527A1 (en) | 2011-10-05 | 2013-04-11 | H. Lundbeck A/S | Quinazoline derivatives as pde10a enzyme inhibitors |
| RU2014123352A (ru) | 2011-11-09 | 2015-12-20 | Эббви Дойчланд Гмбх Унд Ко. Кг | Гетероциклические карбоксамиды, полезные в качестве ингибиторов фосфодиэстеразы типа 10а |
| US20130116241A1 (en) | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
| AR089361A1 (es) | 2011-12-21 | 2014-08-20 | Lundbeck & Co As H | Derivados de quinolina como inhibidores de la enzima pde10a |
| WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
| US9464085B2 (en) | 2012-08-17 | 2016-10-11 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| IN2015DN01900A (enExample) | 2012-09-17 | 2015-08-07 | Abbvie Deutschland | |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| US9790203B2 (en) | 2012-11-26 | 2017-10-17 | Abbvie Inc. | Inhibitor compounds of phosphodiesterase type 10A |
| US9200005B2 (en) | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| EP2970258B1 (en) | 2013-03-14 | 2018-04-18 | AbbVie Deutschland GmbH & Co KG | Novel inhibitor compounds of phosphodiesterase type 10a |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| GB201704714D0 (en) * | 2017-03-24 | 2017-05-10 | Caldan Therapeutics Ltd | Pharmaceutical compounds |
| JP2022501335A (ja) | 2018-09-28 | 2022-01-06 | 武田薬品工業株式会社 | 自閉症スペクトラム障害を治療または予防するためのバリポデクト（Ｂａｌｉｐｏｄｅｃｔ） |
| JP7720847B2 (ja) * | 2019-12-18 | 2025-08-08 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | ハンチンチンタンパク質をイメージングするための化合物及びプローブ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| WO1997034876A1 (en) * | 1996-03-15 | 1997-09-25 | Zeneca Limited | Cinnoline derivatives and use as medicine |
| DE69739986D1 (de) * | 1996-10-01 | 2010-10-21 | Kyowa Hakko Kogyo Kk | Stickstoff enthaltende heterocyclische verbindungen |
| ITMI981671A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| ES2221426T3 (es) * | 1998-08-20 | 2004-12-16 | Smithkline Beecham Corporation | Nuevos compuestos de triazol sustituidos. |
| US20040127470A1 (en) * | 1998-12-23 | 2004-07-01 | Pharmacia Corporation | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| MXPA02012943A (es) * | 2000-08-09 | 2003-05-15 | Astrazeneca Ab | Compuestos de cinolina. |
| US6538029B1 (en) * | 2002-05-29 | 2003-03-25 | Cell Pathways | Methods for treatment of renal cell carcinoma |
| EP1940819A1 (en) * | 2005-08-16 | 2008-07-09 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10 inhibitors |
| MX2008010671A (es) * | 2006-02-21 | 2008-10-01 | Amgen Inc | Derivados de cinolina como inhibidores de fosfodiesterasa 10. |
| EP1991530A1 (en) * | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| WO2007100880A1 (en) * | 2006-02-28 | 2007-09-07 | Amgen Inc. | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| MX2008011257A (es) * | 2006-03-08 | 2008-09-25 | Amgen Inc | Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10. |
-
2005
- 2005-09-02 WO PCT/US2005/031283 patent/WO2006028957A1/en not_active Ceased
- 2005-09-02 AU AU2005282721A patent/AU2005282721A1/en not_active Abandoned
- 2005-09-02 US US11/217,664 patent/US20060160814A1/en not_active Abandoned
- 2005-09-02 CA CA002578996A patent/CA2578996A1/en not_active Abandoned
- 2005-09-02 EP EP05793348A patent/EP1802585A1/en not_active Withdrawn
- 2005-09-02 JP JP2007530389A patent/JP2008512375A/ja active Pending
- 2005-09-02 MX MX2007002592A patent/MX2007002592A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008512375A5 (enExample) | ||
| RU2404163C2 (ru) | Производные 2,3,4,9-тетрагидро-1h-карбазола в качестве антагонистов рецептора crth2 | |
| RU2019137023A (ru) | Пирролопирроловые композиции в качестве активаторов пируваткиназы (pkr) | |
| Guan et al. | Synthesis of some quinoline-2 (1H)-one and 1, 2, 4-triazolo [4, 3-a] quinoline derivatives as potent anticonvulsants | |
| SI2758388T1 (en) | New bicyclic derivatives of dihydroquinolin-2-one | |
| US5482967A (en) | Condensed heterocyclic compounds, their production and use | |
| FI78296C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2-substituerade 4-amino-6,7-dimetoxikinolinderivat. | |
| EP1379523B1 (en) | 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists | |
| EP0994862B1 (en) | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation | |
| CZ351799A3 (cs) | Substituované 3-kyanochinoliny | |
| KR20040097268A (ko) | 퀴놀린 및 이소퀴놀린 유도체, 그의 제조 방법 및항염증제로서의 그의 용도 | |
| JP2004529132A5 (enExample) | ||
| JP2007523152A5 (enExample) | ||
| RU2004138588A (ru) | Соединения | |
| IL298983A (en) | Macrocyclines with P2' heterocyclic groups as factor XIA inhibitors | |
| US7625926B2 (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| JP2002543080A (ja) | ５−ｈｔ受容体リガンドとしての四環系アゼピノインドール化合物 | |
| ZA200502692B (en) | PGD2 receptor antagonists for the treatment of inflammatory diseases | |
| JP2015528821A5 (enExample) | ||
| RU2019136536A (ru) | Ингибиторы гистондеацетилаз (hdac) | |
| JP2008526715A5 (enExample) | ||
| CZ20013660A3 (cs) | Substituované 3-kyano-(1,7),(1,5) a (1,8)-naftyridinové inhibitory tyrosinových kináz | |
| JP3117725B2 (ja) | カイニン酸神経細胞毒性阻害剤及びピリドチアジン誘導体 | |
| RU2006137284A (ru) | Трициклические соединения бензопирана в качестве противоаритмических агентов | |
| BR0004548A (pt) | Derivados i de quinolin-4-ila |